SCHEMBL1779010

SCHEMBL1779010

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccccc3NC(=O)c3cccs3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.48
AURKA O14965 1/20 0.44
TSHR P16473 2/20 0.44
KMT2A Q03164 3/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
FGFR4 P22455 1/20 0.42
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.39
STK33 Q9BYT3 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
APLNR P35414 1/20 0.38
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743308 0.94 AURKA (0.48) RXFP1AURKATSHRKMT2AMAPT
SCHEMBL1779700 0.89 AURKA (0.50) RXFP1AURKAMAPTABL1BCR
SCHEMBL1779328 0.89 RXFP1 (0.44) RXFP1AURKAFGFR4ABL1BCR
SCHEMBL1780795 0.88 AURKA (0.45) RXFP1AURKAFGFR4ABL1BCR
SCHEMBL1778129 0.88 AURKA (0.43) RXFP1AURKAFGFR4ABL1BCR
SCHEMBL1778872 0.86 AURKA (0.46) RXFP1AURKAFGFR4ABL1BCR
SCHEMBL3875203 0.86 TSHR (0.51) RXFP1TSHRKMT2AMAPTMEN1
SCHEMBL1780912 0.86 AURKA (0.49) RXFP1AURKAABL1BCRKDM4E
SCHEMBL1780888 0.86 RXFP1 (0.46) RXFP1AURKATSHRKMT2AMAPT
SCHEMBL1779573 0.86 AURKA (0.43) RXFP1AURKAFGFR4ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943654-B2 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-17 US disclosed